3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
7
Lymphoma, Large B-Cell, Diffuse
5
Leukemia
5
Ovarian Neoplasms
4
Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Precancerous Conditions
3
Neoplasms, Plasma Cell
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Anaplastic
3
Immunoblastic Lymphadenopathy
3
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Central Nervous System Neoplasms
3
Burkitt Lymphoma
3
Adenocarcinoma Of Esophagus
3
Tongue Neoplasms
2
Testicular Germ Cell Tumor
2
Stomach Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Interventions
Cisplatin
99
Radiotherapy
53
Brachytherapy
41
Paclitaxel
37
Carboplatin
36
Surveys and Questionnaires
28
Blood Specimen Collection
20
pembrolizumab
19
Radiation
17
Magnetic Resonance Spectroscopy
17
Drug Therapy
16
Colposcopy
16
Methods
14
Bevacizumab
14
Early Intervention, Educational
12
toripalimab
11
Topotecan
11
Radiotherapy, Intensity-Modulated
11
Papanicolaou Test
11
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
11
Biopsy
11
Mass Screening
10
Gemcitabine
10
Chemoradiotherapy
10
camrelizumab
9
Patient Navigation
9
Papillomavirus Vaccines
9
Nivolumab
9
Fluorodeoxyglucose F18
9
Educational Status
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Neoplasms
×
Microarray Analysis
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled